Research trends and frontiers on antiphospholipid syndrome: a 10-year bibliometric analysis (2012 – 2021)

HIGHLIGHTS

SUMMARY

    Bibliometric analysis has been broadly used in the medical area (Aksoy et_al, 2021; Ma et_al, 2021; Wu et_al, 2021; Zhu et_al, 2021; Shen et_al, 2022). The incidence and prevalence of APS are estimated to be approximately 2.1/100,000 per year and 50/ 100,000, respectively (Duarte-Garcia et_al, 2019). Although CAPS is extremely infrequent, developing in less than 1% of individuals with APS (Rodriguez-Pinto et_al, 2018), treatment must be started Frontiers in Pharmacology Proof from previous studies indicated that higher anticoagulation strength (INR 3.0-4.5) provided no additional benefit . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?